|
Volumn 14, Issue SUPPL. 3, 1998, Pages
|
Development of bivalent rgp120 vaccines to prevent HIV type 1 infection
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GLYCOPROTEIN GP 120;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CONTROLLED STUDY;
DRUG EFFICACY;
HIGH RISK POPULATION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNOGENICITY;
MONONUCLEAR CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTECTION;
RABBIT;
REVIEW;
VACCINE PRODUCTION;
VIRUS NEUTRALIZATION;
AIDS VACCINES;
AMINO ACID SEQUENCE;
ANIMALS;
EPIDEMIOLOGY, MOLECULAR;
HIV ENVELOPE PROTEIN GP120;
HIV INFECTIONS;
HIV-1;
HUMANS;
MACROPHAGES;
MOLECULAR SEQUENCE DATA;
NEUTRALIZATION TESTS;
RABBITS;
T-LYMPHOCYTES;
VARIATION (GENETICS);
|
EID: 0031764239
PISSN: 08892229
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (66)
|
References (78)
|